Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients

Neuroscience Letters

Volumn 436, Issue 1, 2008, Pages 48-51

  Nagesh Babu, G ^a   Kumar, Alok ^a   Kalita, Jayantee ^a   Misra, U K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Interferon ; Neuroinflammation; Nitric oxide; Tuberculous meningitis; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ARTICLE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; TISSUE NECROSIS; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CHILD; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON TYPE II; MALE; MIDDLE AGED; NITRIC OXIDE; TUBERCULOSIS, MENINGEAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41749111343     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.02.060     Document Type: Article

References (35)

1. Akalin H., Akdiş A.C., Mistik R., Helvaci S., and Kiliçturgay K. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis. 26 (1994) 667-674
2. Beutler B., and Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7 (1989) 625-655
3. Bishberg E., Sunderam G., Reichman L.B., and Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann. Intern. Med. 105 (1986) 203-210
4. Bo L., Dawson T.M., Wesselingh S., Mark S., Choi S., Kong P.A., Hanley D., and Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36 (1994) 778-786
5. Chen L., Jiang H., and Wei C. Nitric oxide, TNF-α and IL-8 in cerebrospinal fluids of tuberculous and cryptococcic meningitis. Hunan Yi Ke Da Xue Xue Bao 22 (1997) 514-516
6. Dawson V.L., and Dawson T.M. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10 (1996) 179-190
7. De Vries H.E., Kuiper J., De Boer A.G., Van Berkel T.J.C., and Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49 (1997) 143-155
8. 15N] nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
9. Gutman L.T., Moye J., Zimmer B., and Tian C. Tuberculosis in human immunodeficiency virus-exposed or -infected United States children. Pediatr. Infect. Dis. J. 13 (1994) 963-968
10. Hashimoto M., Ishikawa Y., Goto F., Bando T., Sasakibara Y., and Iriki M. Action site of circulating interleukin-1 on the rabbit brain. Brain Res. 540 (1991) 217-223
11. Jensen M.B., Hegelund I.V., Lomholt N.D., Finsen B., and owens T. IFN-gamma enhances microglial reactions to hippocampal axonal degeneration. J. Neurosci. 20 (2000) 3612-3621
12. Kalita J., and Misra U.K. Brainstem auditory evoked potentials in tubercular meningitis and their correlation with radiological findings. Neurol. India 49 (2001) 51-54
13. Kalita J., and Misra U.K. Effect of methyl prednisolone on sensory motor functions in tuberculous meningitis. Neurol. India 49 (2001) 267-271
14. Kalita J., and Misra U.K. Motor and somatosensory evoked potentials in tuberculous meningitis: a clinico-radiological correlation. Acta Neurol. Scand. 99 (1999) 225-231
15. Kalita J., and Misra U.K. Outcome of tuberculous meningitis at 6 and 12 months: a multiple regression analysis. Int. J. Tuberc. Lung Dis. 3 (1999) 261-265
16. Kalita J., Misra U.K., and Das B.K. SPECT changes and their correlation with EEG changes in tuberculous meningitis. Electromyogr. Clin. Neurophysiol. 42 (2002) 39-44
17. Kalita J., Misra U.K., and Ranjan P. Tuberculous meningitis with pulmonary miliary tuberculosis: a clinicoradiological study. Neurol. India 52 (2004) 194-196
18. Lee S.C., Dickson D.W., Liu W., and Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46 (1993) 19-24
19. Leonard J.M., and Des Prez R.M. Tuberculous meningitis. Infect. Dis. Clin. North Am. 4 (1990) 769-787
20. Low P.S., Lee B.W., Yap H.K., Tay J.S., Lee W.L., Seah C.C., and Ramzan M.M. Inflammatory response in bacterial meningitis: cytokine levels in the cerebrospinal fluid. Ann. Trop. Paediatr. 15 (1995) 55-59
21. Mastroianni C.M., Paoletti F., Lichtner M., D'Agostino C., Vullo V., and Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin. Immunol. Immunopathol. 84 2 (1997) 171-176
22. Misra U.K., Kalita J., Srivastava M., and Mandal S.K. Prognosis of tuberculous meningitis: a multivariate analysis. J. Neurol. Sci. 137 (1996) 57-61
23. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med 329 (1993) 2002-2012
24. Moser M., and Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1 (2000) 199-205
25. Mustafa M.M., Lebel M.H., Ramilo O., Olsen K.D., Reisch J.S., Beutler B., and McCracken Jr. G.H. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115 (1989) 208-213
26. Pouly S., Becher B., Blain M., and Antel J.P. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J. Neuropathol. Exp. Neurol. 59 (2000) 280-286
27. Ranjan P., Kalita J., and misra U.K. Serial study of clinical and CT changes in tuberculous meningitis. Neuroradiology 45 (2003) 277-282
28. Rhodes P., Leone A.M., and Francis P.L. The l-arginine: nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 209 (1995) 590-596
29. Sharief M.K., Ciardi M., and Thomson E.J. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J. Infect. Dis. 166 (1992) 350-358
30. Smith S., Jacobs R.F., and Wilson C.B. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatr. 131 (1997) 16-26
31. Taskiran D., Sagduyu A., Yuceyar N., Kutey F.Z., and Pogun S. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. Int. J. Neurosci. 101 (2000) 65-72
32. Tsenova L., Bergtold A., Freedman V.H., Young R.A., and Kaplan G. Tumor necrosis factor-α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. 96 (1999) 5657-5662
33. Tsenova L., Sokol K., Freedman V.H., and Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J. Infect. Dis. 177 (1998) 1563-1572
34. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J. Clin. Invest. 95 (1995) 1086-1091
35. Udani P.M. BCG vaccination in India and tuberculosis in children: newer facets. Indian J. Pediatr. 61 (1994) 451-462